Lyell Immunopharma (LYEL) Amortizatization of Intangibles (2020 - 2026)

Lyell Immunopharma has reported Amortizatization of Intangibles for 7 years, with the latest figure at $886000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 48.64% year-over-year to $886000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (down 65.78% YoY) and the FY2025 annual result came in at $5.0 million, down 66.22% from the prior year.
• Amortizatization of Intangibles fell to $886000.0 in Q1 2026 per LYEL's latest filing, from $1.1 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $4.4 million in Q1 2024 and troughed at -$475000.0 in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.7 million in 2025 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles soared 998.27% in 2023, then slumped 71.87% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $1.2 million in 2022, then surged by 180.13% to $3.4 million in 2023, then fell by 12.38% to $3.0 million in 2024, then sank by 64.25% to $1.1 million in 2025, then declined by 16.42% to $886000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $886000.0, $1.1 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.